ReviewCureus2025

Exploring the Neuroprotective and Neuropsychiatric Symptom Management Potential of Ketamine in Alzheimer's Disease.

Amy Avakian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.